0000882104-18-000104.txt : 20180927
0000882104-18-000104.hdr.sgml : 20180927
20180927164124
ACCESSION NUMBER: 0000882104-18-000104
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180925
FILED AS OF DATE: 20180927
DATE AS OF CHANGE: 20180927
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stone Christopher Lewis
CENTRAL INDEX KEY: 0001453373
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19756
FILM NUMBER: 181091428
MAIL ADDRESS:
STREET 1: 932 SOUTHWOOD BLVD.
CITY: INCLINE VILLAGE
STATE: NV
ZIP: 89451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PDL BIOPHARMA, INC.
CENTRAL INDEX KEY: 0000882104
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943023969
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 932 SOUTHWOOD BLVD
CITY: INCLINE VILLAGE
STATE: NV
ZIP: 89451
BUSINESS PHONE: 775-832-8500
MAIL ADDRESS:
STREET 1: 932 SOUTHWOOD BLVD
CITY: INCLINE VILLAGE
STATE: NV
ZIP: 89451
FORMER COMPANY:
FORMER CONFORMED NAME: PROTEIN DESIGN LABS INC/DE
DATE OF NAME CHANGE: 19930328
4
1
wf-form4_153808086599965.xml
FORM 4
X0306
4
2018-09-25
0
0000882104
PDL BIOPHARMA, INC.
PDLI
0001453373
Stone Christopher Lewis
C/O PDL BIOPHARMA, INC.
932 SOUTHWOOD BLVD.
INCLINE VILLAGE
NV
89451
0
1
0
0
VP, Gen. Counsel & Secretary
Stock Option (right to buy)
2.52
2018-09-25
4
A
0
339623
0
A
2028-09-25
Common stock
339623.0
339623
D
The stock options will vest on a monthly basis pro rata over the 48 months following January 1, 2018, provided that the recipient's continuous service has not terminated prior to the applicable vesting date, subject to earlier vesting upon a change in control and certain qualifying terminations of employment provided in the severance agreement between the issuer and the recipient.
/s/ Christopher Stone
2018-09-26